Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

Paperchase #2 - Liraglutide and Renal Outcomes in Type 2 Diabetes

Andrew Buelt, DO and Joe Weatherly, DO
00:00
05:04
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

This study looks at the secondary endpoints of the LEADER trial to find the renal benefit to taking Liraglutide in type 2 diabetic patients.  Compared to placebo, this GLP-1 resulted in lower rates of progression to chronic kidney disease.

 

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
Jingle, Jingle Full episode audio for MD edition 178:44 min - 84 MB - M4AHippo Primary Care RAP - December 2017 Summary 310 KB - PDF